Laboratory of Genomics and Proteomics of Disease Vectors, Institute of Parasitology, Biology Centre, AS CR v.v.i., Ceske Budejovice, Czech Republic.
Ticks Tick Borne Dis. 2012 Jun;3(3):117-27. doi: 10.1016/j.ttbdis.2012.03.004. Epub 2012 Apr 20.
Ticks, as obligate hematophagous ectoparasites, impact greatly on animal and human health because they transmit various pathogens worldwide. Over the last decade, several cystatins from different hard and soft ticks were identified and biochemically analyzed for their role in the physiology and blood feeding lifestyle of ticks. All these cystatins are potent inhibitors of papain-like cysteine proteases, but not of legumain. Tick cystatins were either detected in the salivary glands and/or the midgut, key tick organs responsible for blood digestion and the expression of pharmacologically potent salivary proteins for blood feeding. For example, the transcription of two cystatins named HlSC-1 and Sialostatin L2 was highly upregulated in these tick tissues during feeding. Vaccinating hosts against Sialostatin L2 and Om-cystatin 2 as well as silencing of a cystatin gene from Amblyomma americanum significantly inhibited the feeding ability of ticks. Additionally, Om-cystatin 2 and Sialostatin L possessed strong host immunosuppressive properties by inhibiting dendritic cell maturation due to their interaction with cathepsin S. These two cystatins, together with Sialostatin L2 are the first tick cystatins with resolved three-dimensional structure. Sialostatin L, furthermore, showed preventive properties against autoimmune diseases. In the case of the cystatin Hlcyst-2, experimental evidence showed its role in tick innate immunity, since increased Hlcyst-2 transcript levels were detected in Babesia gibsoni-infected larval ticks and the protein inhibited Babesia growth. Other cystatins, such as Hlcyst-1 or Om-cystatin 2 are assumed to be involved in regulating blood digestion. Only for Bmcystatin was a role in tick embryogenesis suggested. Finally, all the biochemically analyzed tick cystatins are powerful protease inhibitors, and some may be novel antigens for developing anti-tick vaccines and drugs of medical importance due to their stringent target specificity.
蜱作为专性吸血的外寄生虫,对动物和人类健康有很大的影响,因为它们在全球范围内传播各种病原体。在过去的十年中,已经从不同的硬蜱和软蜱中鉴定出几种半胱氨酸蛋白酶抑制剂,并对其在蜱的生理和吸血生活方式中的作用进行了生化分析。所有这些半胱氨酸蛋白酶抑制剂都是木瓜蛋白酶样半胱氨酸蛋白酶的有效抑制剂,但不是组织蛋白酶 L 的抑制剂。蜱半胱氨酸蛋白酶抑制剂要么存在于唾液腺和/或中肠中,这些是蜱消化血液和表达具有药理学活性的吸血唾液蛋白的关键蜱器官。例如,在吸血过程中,两种名为 HlSC-1 和 Sialostatin L2 的半胱氨酸蛋白酶抑制剂的转录在这些蜱组织中高度上调。用 Sialostatin L2 和 Om-cystatin 2 对宿主进行疫苗接种以及沉默美洲钝缘蜱的一个半胱氨酸蛋白酶基因,显著抑制了蜱的吸血能力。此外,由于与组织蛋白酶 S 的相互作用,Om-cystatin 2 和 Sialostatin L 具有强烈的宿主免疫抑制特性,可抑制树突状细胞成熟。这两种半胱氨酸蛋白酶,以及 Sialostatin L2 是具有解析的三维结构的第一批蜱半胱氨酸蛋白酶抑制剂。此外,Sialostatin L 具有预防自身免疫性疾病的特性。在半胱氨酸蛋白酶 Hlcyst-2 的情况下,实验证据表明其在蜱固有免疫中的作用,因为在感染巴贝斯虫的幼虫蜱中检测到 Hlcyst-2 转录本水平升高,并且该蛋白抑制巴贝斯虫的生长。其他半胱氨酸蛋白酶,如 Hlcyst-1 或 Om-cystatin 2,被认为参与调节血液消化。只有 Bmcystatin 被认为在蜱胚胎发生中起作用。最后,所有经过生化分析的蜱半胱氨酸蛋白酶抑制剂都是强大的蛋白酶抑制剂,由于其严格的靶标特异性,一些可能成为开发抗蜱疫苗和具有医学重要性的药物的新型抗原。